236 related articles for article (PubMed ID: 17686833)
1. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
Ng TW; Watts GF; Barrett PH; Rye KA; Chan DC
Diabetes Care; 2007 Nov; 30(11):2945-50. PubMed ID: 17686833
[TBL] [Abstract][Full Text] [Related]
2. Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Ng TW; Chan DC; Barrett PH; Watts GF
Clin Sci (Lond); 2009 Oct; 118(1):79-85. PubMed ID: 19456294
[TBL] [Abstract][Full Text] [Related]
3. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
4. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
7. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
8. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet.
Chan DC; Watts GF; Gan SK; Ooi EM; Barrett PH
Diabetes Care; 2010 May; 33(5):1134-9. PubMed ID: 20185740
[TBL] [Abstract][Full Text] [Related]
9. Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome.
Richard C; Couture P; Desroches S; Lichtenstein AH; Lamarche B
Nutr J; 2013 Jun; 12(1):76. PubMed ID: 24499022
[TBL] [Abstract][Full Text] [Related]
10. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
Chan DC; Nguyen MN; Watts GF; Barrett PH
J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity.
Chan DC; Watts GF; Gan S; Wong AT; Ooi EM; Barrett PH
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1043-50. PubMed ID: 20150556
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.
Ooi EM; Barrett PH; Chan DC; Nestel PJ; Watts GF
Atherosclerosis; 2008 Mar; 197(1):139-46. PubMed ID: 17416370
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
17. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
18. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
19. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
20. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]